Aclaris Therapeutics (ACRS) Preferred Dividend Payments (2014 - 2015)
Aclaris Therapeutics' quarterly Preferred Dividend Payments came in at $213000.0 in Q4 2015, down 67.73% year-on-year from $660000.0 in Q4 2014, and down 79.12% quarter-over-quarter from $1.0 million in Q3 2015.
Aclaris Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $213000.0 in Q4 2015.
- For the quarter ending Q4 2015, Preferred Dividend Payments fell 67.73% year-over-year to $213000.0; the trailing twelve-month figure through Dec 2015 stood at $2.6 million (changed N/A YoY), and the FY2015 full-year result was $2.6 million, up 24.93% from the prior year.
- Preferred Dividend Payments for Q4 2015 stood at $213000.0, down from $1.0 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $1.0 million in Q3 2015, with the low at $213000.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Aclaris Therapeutics | 586.09 Mn | 586.09 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 213,000.00 |
| Sep 30, 2015 | 1.02 Mn |
| Jun 30, 2015 | 676,000.00 |
| Mar 31, 2015 | 657,000.00 |
| Dec 31, 2014 | 660,000.00 |
| Sep 30, 2014 | 479,000.00 |